Prediction Case File
YouTubeEvaluation Complete

Hims & Hers has been one of the most volatile stocks in the market.

1 extracted signal · 1 resolved · 0 still active

Parkev Tatevosian, CFA profile imageParkev Tatevosian, CFAIndependent analyst profile
Source published
13 Feb 2026, 17:00 UTC
Recorded by Tahlil Plus
18 May 2026, 20:24 UTC
Video preview for Hims & Hers has been one of the most volatile stocks in the market.
Source overview

AI-generated source summary

Hims & Hers (HIMS) stock has experienced significant volatility, declining over 25% recently after facing patent infringement lawsuits and FDA crackdowns on unapproved compounding. The company is set to report Q4 and full-year 2025 financial results on February 23, 2026. Despite the stock's recent drop, analysts suggest that HIMS's ability to grow its customer base and manufacturing capacity, coupled with its competitive pricing for weight-loss treatments, presents a potential buying opportunity. The company's forward P/E ratio has decreased to 31.89, its lowest point in the past year, indicating a more attractive valuation. Projections show substantial improvements in free cash flow and revenue growth over the next two years, with a target of $0.30 per share in free cash flow by Q4 2027, suggesting a strong underlying business despite current headwinds.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
1
Extracted from this source
Open
0
Still being tracked
Successful
1
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
100%
1 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Source processing completed

    Source analysis and structured extraction completed.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  7. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Analyst snapshot

Parkev Tatevosian, CFA

Platform-wide history, separate from this source evaluation.

Reliability
41.8
Tracked signals
1293
Historical success
25.9%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail